Abstract

Although recent randomized control trial reported that the polymer-coated, paclitaxel-eluting stent (Eluvia) was non-inferior to the polymer-free, paclitaxel-coated stent (Zilver PTX) for femoropopliteal (FP) artery lesion, there are no intravascular ultrasound (IVUS) data about the difference of

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call